Effective November 28, 2023, Aeglea BioTherapeutics, Inc. will change its name to Spyre Therapeutics, Inc.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.58 USD | +3.05% | +4.11% | +61.08% |
Apr. 19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
Apr. 19 | Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.08% | 1.35B | |
-2.63% | 103B | |
+1.75% | 95.28B | |
+1.46% | 22.15B | |
-15.69% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.78% | 16.05B | |
+5.39% | 13.68B | |
+34.29% | 12.17B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Aeglea BioTherapeutics, Inc. will Change its Name to Spyre Therapeutics, Inc